Are GLP-1s a sustainable solution for weight management?
Abarca Health
A forward-thinking PBM on a mission to make healthcare seamless & personalized for everyone. #PBMAwesome
Though the demand for GLP-1s for weight management has skyrocketed in the US in recent years, the prevalence of severe obesity has also been on the rise. ?
While GLP-1s have been proven to help individuals lose weight, they alone are not enough to effectively manage obesity, negate comorbidities, or reduce costs for consumers or plans in the long run.
It is up to us–the healthcare industry–to create holistic strategies that not only address symptoms of chronic conditions but offer lifestyle modifications that will facilitate lasting change and better outcomes for everyone.
Technology is key to a holistic weight management strategy. Advanced, user-friendly tools better engage individuals and healthcare providers, allow for timely interventions, and facilitate personalized strategies that can make an impact. Here’s how to get started.
While GLP-1s have shown near-term weight-loss benefits, there are still many questions about their long-term use that are creating challenges for payers, providers, and patients. Our SVP of Drug Value?Strategy, Nicole Bulochnik, spoke to MedCity News this summer about what payers need to consider when it comes to these drugs.?Read more.
At this year’s Abarca Forward, we convened a panel of weight management experts from across the healthcare ecosystem. Hear their insights.
“We are seeking answers to important questions regarding GLP-1s–such as their long-term effects, optimal usage duration, budget impact, and predictive analytics insights–as weight loss analysis becomes more intricate for our clients.”